Literature DB >> 1826279

Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice.

D Zipris1, A R Crow, T L Delovitch.   

Abstract

Insulitis occurs by 5 wk of age in all NOD mice. However, diabetes is detectable only after 3-5 mo of age and only in approximately 50% of females and 10% of males in our colony. Therefore, it is predictable that changes in the T-lymphocyte repertoire of diabetes-prone mice occur and predispose them to disease. We demonstrate here that an altered (with respect to control BALB/cJ mice) thymic T-lymphocyte maturation reflected by a depletion (approximately 12%) of CD4+CD8+ T lymphocytes and a reciprocal increase in CD4-CD8- T lymphocytes precedes the onset of diabetes. This depletion was detected only approximately 3 mo after insulitis and is manifested by a specific loss (approximately 3%) of immature T lymphocytes bearing V beta 8lo (lo is a relative level of expression) T-lymphocyte receptor. By onset of diabetes, an even greater decrease (approximately 35%) of CD4+CD8+ and a reciprocal increase of CD4-CD8- T lymphocytes were apparent and accompanied by the same depletion (3%) of V beta 8 lo T lymphocytes. Administration of cyclophosphamide (CY), which accelerates the appearance of diabetes in NOD mice, caused similar depletions of CD4+CD8+ and V beta 8lo thymic T lymphocytes. The same alterations in the distribution of these thymic T-lymphocyte subsets were evident even earlier in insulitis- and diabetes-free NON mice, indicating that these changes in thymic T-lymphocyte development may be necessary but not sufficient to give rise to diabetes. Despite the common genetic origin of NOD and NON mice, differences at their MHC-linked and -unlinked loci may account for their differential susceptibility to diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826279     DOI: 10.2337/diab.40.4.429

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

Review 1.  Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.

Authors:  B Singh; T L Delovitch
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

Review 3.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: enterovirus, thymus and type 1 diabetes pathogenesis.

Authors:  H Jaïdane; F Sané; R Hiar; A Goffard; J Gharbi; V Geenen; D Hober
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

4.  In-utero coxsackievirus B4 infection of the mouse thymus.

Authors:  H Jaïdane; A Halouani; H Jmii; F Elmastour; S Abdelkefi; G Bodart; H Michaux; T Chakroun; F Sane; M Mokni; V Geenen; D Hober; M Aouni
Journal:  Clin Exp Immunol       Date:  2016-11-29       Impact factor: 4.330

5.  Interleukin-4: new diabetes champion?

Authors:  A Robinson
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

6.  Identification of a limited T-cell receptor beta chain variable region repertoire associated with diabetes in the BB rat.

Authors:  D P Gold; D Bellgrau
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

7.  The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency.

Authors:  M Prochazka; H R Gaskins; L D Shultz; E H Leiter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice.

Authors:  Pablo A Silveira; Joseph Dombrowsky; Ellis Johnson; Harold D Chapman; David Nemazee; David V Serreze
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

9.  Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-zeta-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice.

Authors:  K Salojin; J Zhang; M Cameron; B Gill; G Arreaza; A Ochi; T L Delovitch
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

10.  Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

Authors:  M J Rapoport; A Jaramillo; D Zipris; A H Lazarus; D V Serreze; E H Leiter; P Cyopick; J S Danska; T L Delovitch
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.